Significant Accounting Policies (Tables) - NorthView Acquisition Corp [Member]
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2025 |
Dec. 31, 2024 |
Summary of Significant Accounting Policies [Line Items] |
|
|
Shedule of Fair Value of Investments Held in Trust Account |
During the three months ended March 31, 2024, pursuant to the trust agreement dated as of December 20, 2021 between the Company and Continental Stock Transfer & Trust Company (“CST”), the trustee of the Trust Account, $28,484 of interest income from the Trust Account was withdrawn by the Company for the payment of franchise and income taxes.
|
|
Fair Value as of March 31, 2025
|
|
Fair Value as of December 31, 2024
|
Cash
|
|
$
|
1,920,401 |
|
$
|
8,330,835 |
|
During the year ended December 31, 2023, pursuant to the trust agreement dated as of December 20, 2021 between the Company and Continental Stock Transfer & Trust Company (“CST”), the trustee of the Trust Account, $1,192,438 of interest income from the Trust Account was withdrawn by the Company for the payment of franchise and income taxes.
|
|
Fair Value as of December 31, 2024
|
|
Fair Value as of December 31, 2023
|
Cash
|
|
$
|
8,330,835 |
|
$
|
1,406 |
U.S. Treasury Bills
|
|
|
—
|
|
|
10,872,000 |
|
|
$
|
8,330,835 |
|
$
|
10,873,406 |
|
Schedule of Basic and Diluted Net Loss Per Share |
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each category of common stock:
|
|
For the Three Months Ended March 31,
|
|
|
2025
|
|
2024
|
|
|
Common stock subject to possible redemption
|
|
Common stock
|
|
Common stock subject to possible redemption
|
|
Common stock
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss
|
|
$
|
(125,913 |
)
|
|
$
|
(993,997 |
)
|
|
$
|
(112,816 |
)
|
|
$
|
(707,461 |
)
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
657,910 |
|
|
|
5,193,750 |
|
|
|
828,228 |
|
|
|
5,193,750 |
|
Basic and diluted net loss per share
|
|
$
|
(0.19 |
)
|
|
$
|
(0.19 |
)
|
|
$
|
(0.14 |
)
|
|
$
|
(0.14 |
)
|
|
The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net (loss) income per share for each category of common stock:
|
|
For the Year Ended December 31, 2024
|
|
For the Year Ended December 31, 2023
|
|
|
Common stock subject to possible redemption
|
|
Common stock
|
|
Common stock subject to possible redemption
|
|
Common stock
|
Basic and diluted net (loss) income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net (loss) income
|
|
$
|
(1,096,239 |
)
|
|
$
|
(7,615,380 |
)
|
|
$
|
562,049 |
|
$
|
599,861 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
747,644 |
|
|
|
5,193,750 |
|
|
|
4,866,356 |
|
|
5,193,750 |
Basic and diluted net (loss) income per share
|
|
$
|
(1.47 |
)
|
|
$
|
(1.47 |
)
|
|
$
|
0.12 |
|
$
|
0.12 |
|
Schedule of Condensed Consolidated Balance Sheet |
As of March 31, 2025 and December 31, 2024, the amount of public common stock reflected on the condensed consolidated balance sheets is reconciled in the following table:
Contingently redeemable common stock, December 31, 2023
|
|
$
|
9,252,208 |
|
Less:
|
|
|
|
|
Partial redemption
|
|
|
(1,683,800 |
)
|
Plus:
|
|
|
|
|
Accretion of redeemable common stock
|
|
|
768,980 |
|
Contingently redeemable common stock, December 31, 2024
|
|
$
|
8,337,388 |
|
Less:
|
|
|
|
|
Partial redemption
|
|
|
(6,510,830 |
)
|
Plus:
|
|
|
|
|
Accretion of redeemable common stock
|
|
|
155,999 |
|
Contingently redeemable common stock, March 31, 2025
|
|
$
|
1,982,557 |
|
|
As of December 31, 2024 and 2023, the amount of public common stock reflected on the consolidated balance sheets is reconciled in the following table:
Contingently redeemable common stock, December 31, 2022
|
|
|
193,525,484 |
|
Less:
|
|
|
|
|
Partial redemption
|
|
|
(186,410,914 |
)
|
Plus:
|
|
|
|
|
Accretion of redeemable common stock
|
|
|
2,137,638 |
|
Contingently redeemable common stock, December 31, 2023
|
|
$
|
9,252,208 |
|
Less:
|
|
|
|
|
Partial redemption
|
|
|
(1,683,800 |
)
|
Plus:
|
|
|
|
|
Accretion of redeemable common stock
|
|
|
768,980 |
|
Contingently redeemable common stock, December 31, 2024
|
|
$
|
8,337,388 |
|
|